These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 26106458)

  • 1. Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis.
    Haider L
    Oxid Med Cell Longev; 2015; 2015():725370. PubMed ID: 26106458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights in the mechanisms of impaired redox signaling and its interplay with inflammation and immunity in multiple sclerosis.
    Michaličková D; Šíma M; Slanař O
    Physiol Res; 2020 Feb; 69(1):1-19. PubMed ID: 31852206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology and disease mechanisms in different stages of multiple sclerosis.
    Lassmann H
    J Neurol Sci; 2013 Oct; 333(1-2):1-4. PubMed ID: 23735777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron and copper in progressive demyelination--New lessons from Skogholt's disease.
    Aspli KT; Flaten TP; Roos PM; Holmøy T; Skogholt JH; Aaseth J
    J Trace Elem Med Biol; 2015; 31():183-7. PubMed ID: 25563774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular basis of neurodegeneration in multiple sclerosis.
    Lassmann H; van Horssen J
    FEBS Lett; 2011 Dec; 585(23):3715-23. PubMed ID: 21854776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis: lessons from molecular neuropathology.
    Lassmann H
    Exp Neurol; 2014 Dec; 262 Pt A():2-7. PubMed ID: 24342027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
    Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.
    Rajda C; Pukoli D; Bende Z; Majláth Z; Vécsei L
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis.
    Wang P; Xie K; Wang C; Bi J
    Eur Neurol; 2014; 72(3-4):249-54. PubMed ID: 25277682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of white matter damage in multiple sclerosis.
    Lassmann H
    Glia; 2014 Nov; 62(11):1816-30. PubMed ID: 24470325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced number and activity of mitochondria in multiple sclerosis lesions.
    Witte ME; Bø L; Rodenburg RJ; Belien JA; Musters R; Hazes T; Wintjes LT; Smeitink JA; Geurts JJ; De Vries HE; van der Valk P; van Horssen J
    J Pathol; 2009 Oct; 219(2):193-204. PubMed ID: 19591199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stressed cybrids model demyelinated axons in multiple sclerosis.
    Llobet L; Gómez-Durán A; Iceta R; Iglesias E; Montoya J; Martín-Martínez J; Ara JR; Ruiz-Pesini E
    Metab Brain Dis; 2013 Dec; 28(4):639-45. PubMed ID: 23612782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple sclerosis - a mitochondria-mediated disease?].
    Varhaug KN; Vedeler CA; Tzoulis C; Bindoff LA
    Tidsskr Nor Laegeforen; 2017 Feb; 137(4):284-287. PubMed ID: 28225235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
    Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
    Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Sclerosis Pathology.
    Lassmann H
    Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 29358320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remyelinating strategies in multiple sclerosis.
    Luessi F; Kuhlmann T; Zipp F
    Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.
    Wang Y; Sun P; Wang Q; Trinkaus K; Schmidt RE; Naismith RT; Cross AH; Song SK
    Brain; 2015 May; 138(Pt 5):1223-38. PubMed ID: 25724201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative/Nitroxidative Stress and Multiple Sclerosis.
    Tobore TO
    J Mol Neurosci; 2021 Mar; 71(3):506-514. PubMed ID: 32767188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of multiple sclerosis and related inflammatory demyelinating diseases.
    Kutzelnigg A; Lassmann H
    Handb Clin Neurol; 2014; 122():15-58. PubMed ID: 24507512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.